GSK PLC-SPON ADR (GSK)       35.3  -0.04 (-0.11%)

35.3  -0.04 (-0.11%)

US37733W2044 - ADR - After market: 35.3599 +0.06 (+0.17%)

GSK PLC-SPON ADR35.3

NYSE:GSK (1/27/2023, 7:11:53 PM)-0.04 (-0.11%)

After market: 35.3599 +0.06 (+0.17%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-02 2022-11-02/bmo Earnings (Next) 02-01 2023-02-01
Ins Owners N/A Inst Owners 0.56%
Market Cap 72.26B Shares 2.05B
PE 9.27 Fwd PE 9.63
Dividend Yield 7.11% Analysts 70
IPO 05-22 1972-05-22

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

GSK Daily chart

Company Profile

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Middlesex and currently employs 90,096 full-time employees. The firm makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. The company develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. The company has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions, including the chronic autoimmune condition lupus, respiratory disease, and human immunodeficiency virus (HIV). Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics and medicines for skin diseases. The company has a global network of about 12 vaccines manufacturing sites.

Company Info

GSK PLC-SPON ADR

980 Great West Road

Brentford MIDDLESEX TW8 9GS

P: 442080475000.0

CEO: Emma Walmsley

Employees: 90096

Website: https://www.gsk.com/

GSK News

News Image4 days ago - MarketBeatHow Could GSK's RSV Vaccine Change its Valuation?

GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.

News Image5 days ago - The Motley Fool3 Penny Stocks That Could Make You Filthy Rich

These low-priced equities could deliver enormous returns for risk-tolerant shareholders.

News Image9 days ago - The Motley FoolCOVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock

Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market.

News Image9 days ago - Investor's Business DailyStock Market Rally Pulls Back; Microsoft, Google Slash Jobs; Netflix, Goldman, Tesla In Focus: Weekly Review

Microsoft and Google are slashing jobs. Netflix and Tesla jumped.

News Image10 days ago - Investor's Business DailyPharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

After years of lab failures, the companies could crack open a multibillion-dollar market.

News Image12 days ago - Seeking AlphaMRNA stock gains as BofA welcomes Phase 3 data for RSV vaccine (NASDAQ:MRNA)

Moderna (MRNA) added ~8% in early trading Wednesday as Bank of America welcomed the company's Phase 3 data for mRNA-1345, its respiratory syncytial virus vaccine. Read the full story here.

GSK Twits

Here you can normally see the latest stock twits on GSK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example